Trial Profile
Prospective study investigating the safety and efficacy of etanercept use in patients with juvenile idiopathic arthritis (JIA) from the JIA Biologics Register
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2020
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 06 Jun 2020 Results (N=2500) presented at the 21st Annual Congress of the European League Against Rheumatism
- 04 Feb 2016 New trial record